Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Cancer Treatment and Research|April 8, 2014
Advances in the management of viral infectionsJack W Hsu, John R WingardExpert Opinion on Biological Therapy|December 26, 2012
The role of monoclonal antibodies in the treatment of lymphomasJack W Hsu, Nam H DangSeminars in Hematology|January 7, 2012
Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantationMaxim Norkin, Jack W Hsu, John R WingardPlos One|March 17, 2015
Uric acid and the prediction models of tumor lysis syndrome in AMLA Ahsan Ejaz, Negiin Pourafshar, Rajesh Mohandas, et al.Mycoses|January 25, 2018
Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropeniaPranatharthi Chandrasekar, Bhawna Sirohi, Nita L Seibel, et al.Bone Marrow Transplantation|June 10, 2018
Pharmacokinetic and clinical outcomes when ideal body weight is used to dose busulfan in obese hematopoietic stem cell transplant recipientsShawn P Griffin, Sarah E Wheeler, Laura E Wiggins, et al.Ejhaem|July 25, 2025
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to TransplantErin A Dean, Rick Y Lin, Tuo Lin, et al.Frontiers in Oncology|September 25, 2025
Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myelomaErin A Dean, Derek M Li, Tuo Lin, et al.Clinical Medicine Insights. Oncology|September 19, 2014
Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant-A Prospective Phase II StudyMichael Byrne, Donya Salmasinia, Helen Leather, et al.Journal of Clinical Apheresis|May 31, 2017
Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantationJan S Moreb, Michael Byrne, Ilicia Shugarman, et al.Pageof 5